Role of interleukin-32 in chronic rhinosinusitis
- PMID: 23242112
- PMCID: PMC3733344
- DOI: 10.1097/ACI.0b013e32835b35d5
Role of interleukin-32 in chronic rhinosinusitis
Abstract
Purpose of review: IL-32 is a recently described proinflammatory cytokine and has been reported to be involved in inflammatory diseases. The purpose of this review is to discuss the role of IL-32 in chronic rhinosinusitis (CRS).
Recent findings: Two groups have recently reported data regarding the expression of IL-32 in CRS. IL-32 was induced by IFN-γ, TNF-α, dsRNA, and incubation with Th1 cells in primary nasal epithelial cells. IL-32 may be elevated in epithelial cells from patients with CRS without nasal polyps. IL-32 was significantly elevated in whole sinonasal tissue samples of nasal polyps compared with control tissue. IL-32 mRNA expression positively correlated with mRNA for CD3 and macrophage mannose receptor in nasal polyp tissue. Immunohistochemical studies demonstrated localization of IL-32 in epithelium, CD3(+) and CD68(+) cells, suggesting that epithelial cells, T cells, and macrophages are the major IL-32-producing cells in CRS. Activation of these cell types may trigger IL-32-related inflammation in CRS.
Summary: Elevated levels of IL-32 may play a role in the pathogenesis of CRS through its role as a proinflammatory cytokine and as an endogenous enhancer of pathogen-dependent cytokine production.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps.Allergy. 2012 Jan;67(1):25-32. doi: 10.1111/j.1398-9995.2011.02706.x. Epub 2011 Sep 7. Allergy. 2012. PMID: 21899560 Free PMC article.
-
Regulation and expression of IL-32 in chronic rhinosinusitis.Allergy. 2012 Jun;67(6):790-8. doi: 10.1111/j.1398-9995.2012.02820.x. Epub 2012 Apr 9. Allergy. 2012. PMID: 22486709
-
CD8(+) T cells with distinct cytokine-producing features and low cytotoxic activity in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.Clin Exp Allergy. 2016 Sep;46(9):1162-75. doi: 10.1111/cea.12758. Epub 2016 Jun 16. Clin Exp Allergy. 2016. PMID: 27176491
-
Mechanisms and pathogenesis of chronic rhinosinusitis.J Allergy Clin Immunol. 2022 May;149(5):1491-1503. doi: 10.1016/j.jaci.2022.02.016. Epub 2022 Mar 1. J Allergy Clin Immunol. 2022. PMID: 35245537 Free PMC article. Review.
-
Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis: review of the evidence.Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):37-44. doi: 10.1097/ACI.0b013e32835b350e. Curr Opin Allergy Clin Immunol. 2013. PMID: 23128419 Review.
Cited by
-
IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis.Mediators Inflamm. 2016;2016:8413768. doi: 10.1155/2016/8413768. Epub 2016 Apr 6. Mediators Inflamm. 2016. PMID: 27143819 Free PMC article. Review.
-
Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.BMC Res Notes. 2014 Aug 7;7:501. doi: 10.1186/1756-0500-7-501. BMC Res Notes. 2014. PMID: 25100201 Free PMC article.
-
IL-32 exacerbates adenoid hypertrophy via activating NLRP3-mediated cell pyroptosis, which promotes inflammation.Mol Med Rep. 2021 Mar;23(3):226. doi: 10.3892/mmr.2021.11865. Epub 2021 Jan 26. Mol Med Rep. 2021. PMID: 33495843 Free PMC article.
-
Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis.Curr Allergy Asthma Rep. 2016 Jan;16(1):3. doi: 10.1007/s11882-015-0583-4. Curr Allergy Asthma Rep. 2016. PMID: 26707380 Free PMC article. Review.
-
Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.Tumour Biol. 2015 Jul;36(7):5265-72. doi: 10.1007/s13277-015-3186-8. Epub 2015 Feb 9. Tumour Biol. 2015. PMID: 25663496
References
-
- Huvenne W, van Bruaene N, Zhang N, et al. Chronic rhinosinusitis with and without nasal polyps: what is the difference? Curr Allergy Asthma Rep. 2009;9:213–220. - PubMed
-
- Kim SH, Han SY, Azam T, et al. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22:131–142. - PubMed
-
- Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992;148:597–603. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials